Laurent Humeau insider trades
Open-market stock purchases and sales by Laurent Humeau, Chief Scientific Officer at Inovio Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 5, 2019.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 20, 2026 | INO Inovio Pharmaceuticals, Inc | Sold (not open market) | $2.7K |
| May 20, 2026 | INO Inovio Pharmaceuticals, Inc | Bought (not open market) | — |
| May 20, 2026 | INO Inovio Pharmaceuticals, Inc | Bought (not open market) | — |
| May 20, 2026 | INO Inovio Pharmaceuticals, Inc | Bought (not open market) | — |
| May 15, 2026 | INO Inovio Pharmaceuticals, Inc | Sold (not open market) | $2.2K |
| May 15, 2026 | INO Inovio Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 4, 2026 | INO Inovio Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 4, 2026 | INO Inovio Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 26, 2026 | INO Inovio Pharmaceuticals, Inc | Sold (not open market) | $3.7K |
| Feb 26, 2026 | INO Inovio Pharmaceuticals, Inc | Sold (not open market) | $5.4K |
| Feb 26, 2026 | INO Inovio Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 26, 2026 | INO Inovio Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- INO Inovio Pharmaceuticals, Inc: 2 buys, 5 sales, last May 20, 2026